Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Kintor Pharmaceutical Announced FDA Has Greenlighted Pyrilutamide's Phase II Clinical Trial for Androgenetic Alopecia in the US 2021-07-11 21:03
IS3NA Announces the 2021 Virtual Symposium 2021-07-10 20:00
ABL Bio Announces Publication of Preclinical Data Demonstrating Safety and Efficacy of ABL503/TJ-L14B, a Novel Anti-PD-L1 X 4-1BB Bispecific Antibody 2021-07-09 21:00
I-Mab Expands Emerging Portfolio of Next Generation Novel Oncology Therapeutics Through Cutting-Edge mRNA and AI Technology Platforms 2021-07-09 20:00
Vaniam Group LLC announces European and International expansion with addition of new global agency, Vaniam Group Global Ltd 2021-07-09 06:50
Just 5 minutes: Game-changing PCR to complete nucleic acid amplification, Si-Gene Biotech help out against COVID 19 2021-07-08 11:28
Biocytogen/Eucure Biopharma's CTLA-4 and CD40 mAbs Approved for Phase II Clinical Trials by the FDA 2021-07-07 16:41
LBB Specialties Enters Agreement with Leading Innovative Actives Manufacturer GREAF 2021-07-07 01:45
Immunogenicity Expert and FDA Alum Dr. Amy Rosenberg Joins EpiVax 2021-07-07 01:43
Seegene announces partnership with Bio-Rad to develop diagnostic testing products for the U.S. Market 2021-07-06 18:00
Inbiose applies for FDA GRAS approval of four new Human Milk Oligosaccharides 2021-07-06 15:00
Exyte Delivers Excellent First Quarter 2021 2021-07-06 14:55
Clover Biopharmaceuticals Completes Enrollment of Adult and Elderly Population in SPECTRA Global Phase 2/3 Clinical Trial for its COVID-19 Vaccine Candidate 2021-07-06 14:00
South-Korean biotech Y-Biologics and French mid-pharma Pierre Fabre enter into a worldwide exclusive license agreement in the highly innovative field of immuno-oncology 2021-07-06 07:00
Korea National Institute of Health (KNIH) conducts field inspection of companies with mRNA technology 2021-07-01 21:00
I-Mab Announces Multiple Advancements of 4-1BB Bispecific Antibody Portfolio 2021-07-01 20:00
I-Mab Honored with Top Rankings by Institutional Investor 2021-06-30 20:00
Clover Announces Advance Purchase Agreement with Gavi for Over 400 Million Doses of Clover's COVID-19 Vaccine for the COVAX Facility 2021-06-30 16:00
Clover and Dynavax Announce Commercial Supply Agreement of Dynavax's CpG 1018 Adjuvant for Clover's COVID-19 Vaccine Candidate 2021-06-30 16:00
OnCusp Therapeutics Commences Operations to Advance Innovative Oncology Therapies 2021-06-30 09:29
1 141 142 143 144 145 151